Science Explorer Back to mapMap
Discussion
Company · San Francisco · ??

Accelero Biostructures

Research works
1
▲ 370% vs 2018-21
Citations
7
6.1 per fractional work
Top-10% rate
5.3%
all institutions 10.0%
Open access
100%
world 40%
International
21%
world 18%

Not ranked overall: Accelero Biostructures is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Accelero Biostructures work in?

In all years, 50% of research at Accelero Biostructures is in Physical Sciences, 42% in Life Sciences. Its largest fields are Computer Science (50%), Biochemistry, Genetics and Molecular Biology (42%), Medicine (8%).

Life Sciences42%Physical Sciences50%Health Sciences8%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 3 fields, with their numbers
    1. Computer Science150.0%
    1. Biochemistry, Genetics and Molecular Biology041.7%
    1. Medicine08.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Accelero Biostructures?

The most cited paper from Accelero Biostructures is "Fragment- and structure-based drug discovery for developing therapeutic agents targeting the DNA Damage Response" (David M. Wilson, Ashley M. Deacon, Matthew A. J. Duncton et al., 2020), with 38 citations. Next come "Structures of single‐layer β‐sheet proteins evolved from β‐hairpin repeats" (13) and "A New Drug Discovery Platform: Application to DNA Polymerase Eta and Apurinic/Apyrimidinic Endonuclease 1" (7).

Most cited papers
#PaperReleasedCitations
1 Fragment- and structure-based drug discovery for developing therapeutic agents targeting the DNA Damage Response David M. Wilson, Ashley M. Deacon, Matthew A. J. Duncton et al. · Progress in Biophysics and Molecular Biology Open access 25 Oct 2020 38
2 Structures of single‐layer β‐sheet proteins evolved from β‐hairpin repeats Qingping Xu, Matthew Biancalana, Joanna C. Grant et al. · Protein Science Open access 15 Jul 2019 13
3 A New Drug Discovery Platform: Application to DNA Polymerase Eta and Apurinic/Apyrimidinic Endonuclease 1 Debanu Das, Matthew A. J. Duncton, Taxiarchis M. Georgiadis et al. · International Journal of Molecular Sciences Open access 23 Nov 2023 7
4 Rapid hits, hotspots and hit-to-lead by crystallographic library screening: case studies in targeting proteins for novel drug discovery Debanu Das, Ashley M. Deacon, Matthew A. J. Duncton · Acta Crystallographica Section A Foundations and Advances Open access 22 Aug 2023 0
All 4 most cited papers, with filters and sorting

Which research topics does Accelero Biostructures publish most on?

By volume in 2022-now: Computational Drug Discovery Methods, Genetics, Bioinformatics, and Biomedical Research, HIV/AIDS drug development and treatment and DNA Repair Mechanisms.

  1. 1 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
  2. 2 Genetics, Bioinformatics, and Biomedical Research Molecular Biology 0 works
  3. 3 HIV/AIDS drug development and treatment Infectious Diseases 0 works
  4. 4 DNA Repair Mechanisms Molecular Biology 0 works
  5. 5 Biochemical and Molecular Research Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available100.0%

World: 40% of research is openly available.

with international co-authors20.7%domestic only79.3%

World: 18% is written across borders.

How has Accelero Biostructures's research output changed?

Output in 2022-2025 was 370% higher than in 2018-2021.

still counting20202025

Other research institutions in San Francisco

All research institutions in San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Accelero Biostructures. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.